GHO Capital-backed Velocity Clinical Research completed the acquisition of Meridian Clinical Research.

GHO Capital-backed Velocity Clinical Research, an integrated research site organization, completed the acquisition of Meridian Clinical Research, a multi-specialty site network. Financial terms were not disclosed. "Having admired Nicole Osborn and the Meridian team’s approach to clinical research for some time now, I am particularly pleased to welcome them to Velocity. The combination of two of the best businesses in this sector moves the needle for clients, changing the relationship from transactional to strategic," Paul Evans, Velocity President and CEO.